The main health threat in developing states today is not plagues or parasites but illnesses such as cancer and diabetes, noncommunicable diseases long associated with the rich world.

Thomas J. Bollyky discusses President Obama's nomination of Jim Yong Kim to lead the World Bank.

Bollyky outlines the integrated strategy that U.S. policymakers should adopt to overcome the challenges of regulating in an era of global supply chains and achieve better outcomes for U.S. consumers, businesses, and trading partners alike.

A comprehensive new study of the world's health status has the potential to dramatically improve how developing countries address surging problems like noncommunicable diseases, writes CFR's Thomas Bollyky.

Thomas Bollyky assesses President Obama's record in promoting international science in the latest issue of Science. The president has made strides in integrating science into U.S. diplomacy and international development activities, but only modest progress on facilitating the day-to-day scientific exchanges that account for most international research.

CFR Senior Fellow Thomas J. Bollyky contributes to this volume the chapter "Regulatory Coherence in the TPP Talks."

CFR Senior Fellow Thomas J. Bollyky contributes to this volume the chapter "Non-communicable Diseases and the New Global Health."

One year after the UN's high-level meeting on noncommunicable diseases, little progress has been made in generating momentum and new resources. But with the right focus and strategies, there is room to move forward, says CFR's Thomas Bollyky.

Despite not delivering major mandates, the summit could start a new process for sustainable development and open opportunities for new stakeholders, says CFR's Thomas Bollyky.

Bollyky outlines the integrated strategy that U.S. policymakers should adopt to overcome the challenges of regulating in an era of global supply chains and achieve better outcomes for U.S. consumers, businesses, and trading partners alike.

The World Health Assembly in Geneva this week needs to do more to define a workable mission for the struggling World Health Organization.

The main health threat in developing states today is not plagues or parasites but illnesses such as cancer and diabetes, noncommunicable diseases long associated with the rich world.

CFR Senior Fellow Thomas J. Bollyky and the Center for Global Development's director of global health policy Amanda Glassman propose using an innovative incentive mechanism, Cash-on-Delivery (COD) Aid, to improve tobacco control in developing countries.

Thomas J. Bollyky discusses President Obama's nomination of Jim Yong Kim to lead the World Bank.

The winner of the 2012 presidential election faces an important leadership test on trade, which will have challenges and opportunities, says CFR's Thomas Bollyky, including leveling the playing field with China and finalizing the Trans-Pacific Partnership.

Thomas Bollyky examines strategies to improve access to neglected disease treatments and sustainably meet the treatment needs of the world's poorest people.

The 2011 high-level UN meeting on non-communicable diseases fell far short of the major funding and targets agreed to at a similar meeting on HIV/AIDS a decade ago, which CFR's Thomas Bollyky says indicates a need for different actors and approaches on chronic diseases.

Tobacco is reemerging as a polarizing issue in U.S. trade policy. New trade agreement negotiations are forcing the White House to choose between the tobacco debate's partisans. This policy innovation memorandum proposes a new strategy by which the Obama administration can better balance U.S. mandates on trade policy on tobacco with its interests in promoting global health and U.S. standing abroad.

Thomas J. Bollyky discusses tobacco's reemergence as a polarizing issue in U.S. trade policy.